5 products found
BlueWillow Biologics Products
-
NanoVax - Adjuvant Technology
BlueWillow’s vaccine technology incorporates nano-scale droplets that are manufactured at an average size of 400–500 nanometers to deliver and adjuvant a broad spectrum of ...
-
BlueWillow - Vaccine Pipeline
BlueWillow’s intranasal vaccine technology has demonstrated safety and immunogenicity in Phase 1 clinical studies using a seasonal influenza vaccine. Several other ongoing BlueWillow programs — including intranasal vaccines for anthrax, pandemic influenza, RSV, HSV-2 and chlamydia — have recently advanced through successful challenge studies in the respective primary animal model. Click on a program below for details on our research ...
-
BlueWillow - Anthrax Vaccine
Anthrax, though most commonly occurring in animals, can be extremely deadly to humans. Current vaccines can cause acute side effects and may provide only partial protection against some anthrax strains. Tests demonstrate that BlueWillow’s proprietary nanoemulsion (NE) adjuvant could deliver the next generation of anthrax ...
-
BlueWillow - Herpes Simplex Virus-2 Vaccine (HSV-2)
Herpes simplex virus-2 (HSV-2) is the leading cause of genital herpes, a sexually transmitted disease affecting over 500 million people worldwide. BlueWillow’s intranasal nanoemulsion (NE) vaccine is uniquely suited to offer protection against this painful and distressing affliction, through its ability to elicit both a systemic and mucosal immune ...
-
BlueWillow - Peanut Allergy Vaccine
Food allergy has become a significant health problem with increasing incidence and severity, particularly in children but continuing throughout adulthood. There is no cure for food allergy, and allergic reactions can be life threatening. According to the Centers for Disease Control, an estimated 8% of children in the U.S. are now affected by food allergies, or roughly 2 students per ...